Susquehanna Maintains Positive on MaxLinear, Lowers Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
Susquehanna analyst Christopher Rolland maintains a positive outlook on MaxLinear (NASDAQ:MXL), but has lowered the price target from $40 to $30.
October 24, 2023 | 3:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Susquehanna analyst has maintained a positive outlook on MaxLinear but lowered the price target from $40 to $30.
The news directly pertains to MaxLinear. The positive outlook maintained by the analyst indicates confidence in the company's performance, which could be positive for the stock. However, the lowering of the price target might indicate a potential downside, making the short-term impact neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100